8-K 1 d8k.txt FORM 8-K SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 29, 2001 DrugMax, Inc. ------------- Formerly known as DrugMax.com, Inc. ----------------------------------- (Exact name of registrant as specified in its charter) STATE OF NEVADA 1-15445 34-1755390 --------------- ------- ---------- (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
12505 Starkey Road, Suite A Largo, Florida 33773 (Address of principal executive offices) Registrant's telephone number, including area code: (727) 533-0431 Item 5. Other Events. ------------ On October 29, 2001, DrugMax, Inc. (the "Company") issued a press release to announce the finalization of the Company's loan modification agreement with LaSalle Business Credit, Inc. formerly Mellon Business Credit. A copy of the press release, which is incorporated by reference herein and made a part hereof, is filed with this Current Report on Form 8-K as Exhibit 99. Item 7. Financial Statements and Exhibits. ---------------------------------- (c) Exhibits. --------- Exhibit Number Exhibit Description ------- ------------------- 99.1 Press Release dated October 29, 2001. SIGNATURE --------- Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized. DRUGMAX, INC. By: /s/ William L. LaGamba ----------------------------------- William L. LaGamba, President and Chief Operations Officer Dated: October 29, 2001 ------------------------- EXHIBIT INDEX Exhibit Number Exhibit Description ------ ------------------- 99.1 Press Release, dated October 29, 2001.